Cirugía, Ciencias Médicas y Sociales
Departamento
University of Bonn
Bonn, AlemaniaPublicacions en col·laboració amb investigadors/es de University of Bonn (7)
2024
-
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2
Ophthalmology, Vol. 131, Núm. 8, pp. 914-926
2020
-
RANIBIZUMAB TREATMENT IN TREATMENT-NAIVE NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Results From LUMINOUS, a Global Real-World Study
Retina (Philadelphia, Pa.), Vol. 40, Núm. 9, pp. 1673-1685
-
Reply
Retina (Philadelphia, Pa.)
2018
-
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials
JAMA Ophthalmology, Vol. 136, Núm. 6, pp. 666-677
2013
-
Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme
British Journal of Ophthalmology, Vol. 97, Núm. 9, pp. 1161-1167
2012
-
Mortality after surgery in Europe: A 7 day cohort study
The Lancet, Vol. 380, Núm. 9847, pp. 1059-1065